PDB Short entry for 1QLF HEADER IMMUNE SYSTEM/PEPTIDE 30-AUG-99 1QLF TITLE MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G COMPND MOL_ID: 1; COMPND 2 MOLECULE: MHC CLASS I H-2DB HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAINS; COMPND 5 SYNONYM: DB, H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, D-B ALPHA CHAIN, COMPND 6 (H-2D(B)); COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: FORMS HETEROTRIMER WITH CHAIN B (BETA-2-MICROGLOBULIN) COMPND 9 AND CHAIN C (PEPTIDE ANTIGEN); COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: HUMAN BETA-2-MICROGLOBULIN; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: MHC ASSOCIATED LIGHT CHAIN; COMPND 14 SYNONYM: B2M; COMPND 15 ENGINEERED: YES; COMPND 16 OTHER_DETAILS: FORMS HETEROTRIMER WITH CHAIN A AND CHAIN C; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: SYNTHETIC GLYCOPEPTIDE; COMPND 19 CHAIN: C; COMPND 20 FRAGMENT: H-2DB-BOUND GLYCOPEPTIDE FROM NUCLEOCAPSID PROTEIN; COMPND 21 ENGINEERED: YES; COMPND 22 OTHER_DETAILS: PEPTIDE DERIVED FROM SENDAI VIRUS NUCLEOPROTEIN COMPND 23 RESIDUES 324-332, GLY327 HAS BEEN REPLACED BY AN O-GLCNAC SUBSTITUTED COMPND 24 SERINE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL: MOST NUCLEATED CELLS; SOURCE 6 CELLULAR_LOCATION: CELL SURFACE; SOURCE 7 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_CELL: CHO K1 CELLS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 CELL: MOST NUCLEATED CELLS; SOURCE 15 CELLULAR_LOCATION: CELL SURFACE; SOURCE 16 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 18 EXPRESSION_SYSTEM_CELL: CHO K1 CELLS; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: SENDAI VIRUS; SOURCE 22 ORGANISM_TAXID: 11191 KEYWDS IMMUNE SYSTEM/PEPTIDE, MURINE CLASS I MHC-PEPTIDE COMPLEX, MHC, KEYWDS 2 GLYCOPEPTIDE, ANTIGEN, HISTOCOMPATIBILITY, IMMUNOLOGY, IMMUNE KEYWDS 3 SYSTEM-PEPTIDE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.TORMO,E.Y.JONES REVDAT 6 13-DEC-23 1QLF 1 HETSYN REVDAT 5 29-JUL-20 1QLF 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 12-JUL-17 1QLF 1 REVDAT 3 24-MAR-09 1QLF 1 REMARK MASTER REVDAT 2 24-FEB-09 1QLF 1 VERSN REVDAT 1 01-SEP-99 1QLF 0 JRNL AUTH A.GLITHERO,J.TORMO,J.S.HAURUM,G.ARSEQUELL,G.VALENCIA, JRNL AUTH 2 J.EDWARDS,S.SPRINGER,A.TOWNSEND,Y.-L.PAO,M.WORMALD,R.A.DWEK, JRNL AUTH 3 E.Y.JONES,T.ELLIOT JRNL TITL CRYSTAL STRUCTURES OF TWO H-2DB/GLYCOPEPTIDE COMPLEXES JRNL TITL 2 SUGGEST A MOLECULAR BASIS FOR CTL CROSS-REACTIVITY JRNL REF IMMUNITY V. 10 63 1999 JRNL REFN ISSN 1074-7613 JRNL PMID 10023771 JRNL DOI 10.1016/S1074-7613(00)80007-2 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.5 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 14614 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1480 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.74 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1276 REMARK 3 BIN R VALUE (WORKING SET) : 0.2690 REMARK 3 BIN FREE R VALUE : 0.3220 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 133 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3164 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.32000 REMARK 3 B22 (A**2) : -8.58000 REMARK 3 B33 (A**2) : 17.91000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.25000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.50 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.330 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.280 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.730 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.700 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 23.80 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : GOL.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 4 : GOL.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE CARBOHYDRATE ATTACHED TO THE REMARK 3 GLYCOPEPTIDE IS DISORDERED. ONLY ONE OF THE TWO MAJOR REMARK 3 CONFORMATIONS HAS BEEN MODELLED WITH HALF OCCUPANCY. REMARK 4 REMARK 4 1QLF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-AUG-99. REMARK 100 THE DEPOSITION ID IS D_1290004042. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14363 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.17000 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 0.5 REMARK 200 STARTING MODEL: PDB ENTRY 1CE6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.13600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 44 146.95 177.24 REMARK 500 LEU A 114 107.16 -170.17 REMARK 500 TYR A 123 -73.69 -116.89 REMARK 500 LYS A 253 51.74 -94.56 REMARK 500 PRO B 32 -177.34 -65.81 REMARK 500 LEU B 54 137.37 -38.45 REMARK 500 TRP B 60 -6.97 76.02 REMARK 500 TYR C 6 -89.75 -95.15 REMARK 500 REMARK 500 REMARK: NULL DBREF 1QLF A 1 276 UNP P01899 HA11_MOUSE 25 300 DBREF 1QLF B 1 99 UNP P01884 B2MG_HUMAN 21 119 DBREF 1QLF C 1 9 UNP P04857 NCAP_SENDE 324 332 SEQADV 1QLF SER C 4 UNP P04857 GLY 327 ENGINEERED MUTATION SEQRES 1 A 276 GLY PRO HIS SER MET ARG TYR PHE GLU THR ALA VAL SER SEQRES 2 A 276 ARG PRO GLY LEU GLU GLU PRO ARG TYR ILE SER VAL GLY SEQRES 3 A 276 TYR VAL ASP ASN LYS GLU PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA GLU ASN PRO ARG TYR GLU PRO ARG ALA PRO TRP MET SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP GLU ARG GLU THR GLN SEQRES 6 A 276 LYS ALA LYS GLY GLN GLU GLN TRP PHE ARG VAL SER LEU SEQRES 7 A 276 ARG ASN LEU LEU GLY TYR TYR ASN GLN SER ALA GLY GLY SEQRES 8 A 276 SER HIS THR LEU GLN GLN MET SER GLY CYS ASP LEU GLY SEQRES 9 A 276 SER ASP TRP ARG LEU LEU ARG GLY TYR LEU GLN PHE ALA SEQRES 10 A 276 TYR GLU GLY ARG ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 276 LYS THR TRP THR ALA ALA ASP MET ALA ALA GLN ILE THR SEQRES 12 A 276 ARG ARG LYS TRP GLU GLN SER GLY ALA ALA GLU HIS TYR SEQRES 13 A 276 LYS ALA TYR LEU GLU GLY GLU CYS VAL GLU TRP LEU HIS SEQRES 14 A 276 ARG TYR LEU LYS ASN GLY ASN ALA THR LEU LEU ARG THR SEQRES 15 A 276 ASP SER PRO LYS ALA HIS VAL THR HIS HIS PRO ARG SER SEQRES 16 A 276 LYS GLY GLU VAL THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 276 TYR PRO ALA ASP ILE THR LEU THR TRP GLN LEU ASN GLY SEQRES 18 A 276 GLU GLU LEU THR GLN ASP MET GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA SER VAL SEQRES 20 A 276 VAL VAL PRO LEU GLY LYS GLU GLN ASN TYR THR CYS ARG SEQRES 21 A 276 VAL TYR HIS GLU GLY LEU PRO GLU PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 PHE ALA PRO SER ASN TYR PRO ALA LEU MODRES 1QLF SER C 4 SER GLYCOSYLATION SITE HET GOL A 301 6 HET SO4 A 302 5 HET GOL B 100 6 HET NAG C 400 14 HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 GOL 2(C3 H8 O3) FORMUL 5 SO4 O4 S 2- FORMUL 7 NAG C8 H15 N O6 FORMUL 8 HOH *160(H2 O) HELIX 1 1 ALA A 49 GLU A 53 5 5 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 GLY A 151 1 15 HELIX 4 4 GLY A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 LEU A 180 1 6 SHEET 1 A 5 LYS A 31 ASP A 37 0 SHEET 2 A 5 ARG A 21 VAL A 28 -1 N VAL A 28 O LYS A 31 SHEET 3 A 5 HIS A 3 VAL A 12 -1 N VAL A 12 O ARG A 21 SHEET 4 A 5 THR A 94 LEU A 103 -1 N LEU A 103 O HIS A 3 SHEET 5 A 5 LEU A 109 TYR A 118 -1 N ALA A 117 O GLN A 96 SHEET 1 B 2 ILE A 124 LEU A 126 0 SHEET 2 B 2 TRP A 133 ALA A 135 -1 N THR A 134 O ALA A 125 SHEET 1 C 4 LYS A 186 PRO A 193 0 SHEET 2 C 4 GLU A 198 LEU A 206 -1 N LEU A 206 O LYS A 186 SHEET 3 C 4 LYS A 243 PRO A 250 -1 N VAL A 249 O VAL A 199 SHEET 4 C 4 MET A 228 LEU A 230 -1 N GLU A 229 O SER A 246 SHEET 1 D 3 THR A 214 LEU A 219 0 SHEET 2 D 3 TYR A 257 TYR A 262 -1 N TYR A 262 O THR A 214 SHEET 3 D 3 LEU A 270 LEU A 272 -1 N LEU A 272 O CYS A 259 SHEET 1 E 3 LYS B 6 SER B 11 0 SHEET 2 E 3 SER B 20 SER B 28 -1 N SER B 28 O LYS B 6 SHEET 3 E 3 LEU B 64 THR B 71 -1 N PHE B 70 O ASN B 21 SHEET 1 F 3 ILE B 35 LYS B 41 0 SHEET 2 F 3 TYR B 78 HIS B 84 -1 N ASN B 83 O GLU B 36 SHEET 3 F 3 LYS B 91 LYS B 94 -1 N VAL B 93 O CYS B 80 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.05 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 LINK OG SER C 4 C1 NAG C 400 1555 1555 1.43 CISPEP 1 TYR A 209 PRO A 210 0 -1.09 CISPEP 2 HIS B 31 PRO B 32 0 0.14 CRYST1 61.073 58.272 77.146 90.00 108.57 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016374 0.000000 0.005501 0.00000 SCALE2 0.000000 0.017161 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013674 0.00000